Metoclopramide Genethics Europe

Metoclopramide Hydrochloride, the active ingredient in Metoclopramide Genethics Europe, is a dopamine D2 receptor antagonist presented as an oral formulation for systemic use. It treats nausea, vomiting and related gastrointestinal motility disorders in adults, including gastroparesis and gastroesophageal reflux disease.

GNH USA supplies Metoclopramide Genethics Europe as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metoclopramide is used to manage disorders of nausea, vomiting and gastrointestinal motility.

Nausea and vomiting: Reduces frequency and severity of symptoms by blocking dopamine receptors in the chemoreceptor trigger zone. Gastroparesis: Improves gastric emptying and alleviates related discomfort. Gastroesophageal reflux disease: Enhances lower esophageal sphincter tone and promotes gastric clearance.

Metoclopramide may cause a range of adverse reactions.

Common Side Effects: - Drowsiness: feeling of sleepiness or reduced alertness. - Fatigue: general lack of energy. - Restlessness: inner sense of unease or agitation. - Diarrhea: loose, frequent stools.

Serious or Rare Side Effects: - Tardive dyskinesia: involuntary, repetitive movements that may be irreversible. - Neuroleptic malignant syndrome: high fever, muscle rigidity, and autonomic instability. - Severe allergic reaction: rash, swelling, or difficulty breathing. - Cardiac arrhythmia: irregular heart rhythm requiring medical attention.

When prescribing Metoclopramide, several safety considerations apply. - Pregnancy: Use only if potential benefit justifies risk; safety not established. - Breastfeeding: Caution advised; drug may be excreted in milk. - Elderly patients: Start with lower dose and monitor for extrapyramidal symptoms. - Renal impairment: Adjust dose as needed and monitor renal function. - CNS disorders: Use cautiously in patients with Parkinson's disease or seizure disorders. - Store at ambient temperature: keep below 25°C in the original pack, protect from moisture.

Metoclopramide can interact with several medicines.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Anticholinergic agents: may increase anticholinergic side effects. - CNS depressants (e.g., opioids, benzodiazepines): enhanced sedation and respiratory depression. - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): increased metoclopramide plasma levels.

Moderate Interactions (Monitor Closely): - Antipsychotics (e.g., haloperidol): additive extrapyramidal effects. - Digoxin: possible increase in digoxin levels. - Alcohol: may potentiate central nervous system effects. - Proton pump inhibitors: may affect absorption.